Skip to main content
. 2020 Mar 16;26:102248. doi: 10.1016/j.nicl.2020.102248

Fig. 3.

Fig 3

Distribution of Predicted Probabilities for the SARA Model for Specific Diagnoses in the Clinical Cohort

Figure 3 displays the distribution of the SARA model's output in the Clinical Cohort using more specific diagnoses than the AD and Non-AD binary from Figure 1b. Figure 3a displays the specific AD diagnoses along with the combined Non-AD Diagnoses line taken from Fig. 2b. Fig. 3b displays the specific Non-AD diagnoses that are non-neurodegenerative in nature and overlays the combined AD Diagnoses line. 3c displays the specific Non-AD diagnoses that are neurodegenerative in nature and overlays the combined AD Diagnoses line. Note the change in y-axes scale from Fig. 2 due to the tight distribution of CN patients in 3b.

Abbreviations: AD – Alzheimer disease; CN – Cognitively Normal; SARA – Select Atrophied Regions in Alzheimer disease